- Home
- BBW vs IMTX Comparison
BBW vs IMTX Comparison
Compare BBW & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBW
- IMTX
- Stock Information
- Founded
- BBW 1997
- IMTX N/A
- Country
- BBW United States
- IMTX Germany
- Employees
- BBW N/A
- IMTX N/A
- Industry
- BBW Recreational Games/Products/Toys
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BBW Consumer Discretionary
- IMTX Health Care
- Exchange
- BBW Nasdaq
- IMTX Nasdaq
- Market Cap
- BBW 801.4M
- IMTX 865.5M
- IPO Year
- BBW 2004
- IMTX N/A
- Fundamental
- Price
- BBW $57.80
- IMTX $9.39
- Analyst Decision
- BBW Strong Buy
- IMTX Strong Buy
- Analyst Count
- BBW 5
- IMTX 5
- Target Price
- BBW $68.80
- IMTX $15.00
- AVG Volume (30 Days)
- BBW 439.8K
- IMTX 815.8K
- Earning Date
- BBW 08-28-2025
- IMTX 11-17-2025
- Dividend Yield
- BBW 1.52%
- IMTX N/A
- EPS Growth
- BBW 25.62
- IMTX N/A
- EPS
- BBW 4.47
- IMTX N/A
- Revenue
- BBW $522,518,000.00
- IMTX $152,823,253.00
- Revenue This Year
- BBW $8.36
- IMTX N/A
- Revenue Next Year
- BBW $3.62
- IMTX N/A
- P/E Ratio
- BBW $12.96
- IMTX N/A
- Revenue Growth
- BBW 8.10
- IMTX 83.61
- 52 Week Low
- BBW $32.55
- IMTX $3.30
- 52 Week High
- BBW $75.85
- IMTX $11.40
- Technical
- Relative Strength Index (RSI)
- BBW 38.45
- IMTX 78.64
- Support Level
- BBW $70.07
- IMTX $6.90
- Resistance Level
- BBW $74.38
- IMTX $9.54
- Average True Range (ATR)
- BBW 2.87
- IMTX 0.47
- MACD
- BBW -2.05
- IMTX 0.25
- Stochastic Oscillator
- BBW 2.16
- IMTX 95.21
About BBW Build-A-Bear Workshop Inc.
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.